Clinical Trial: Safety, Efficacy and Pharmacokinetics of BTA-C585 in a RSV Viral Challenge Study

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: A Randomised, Phase 2a, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Antiviral Activity Against Respiratory Syncytial Virus Infection, and the Pharmacokinetics of Multiple Oral Do

Brief Summary: The primary purpose of this study is to evaluate the antiviral activity of oral BTA-C585 compared to placebo in healthy volunteers after intranasal challenge with RSV-A Memphis 37b virus.